TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Other Non-Current Assets of $69000.0 for Q1 2026, down 83.73% year-over-year from $424000.0 in Q1 2025, and down 83.49% quarter-over-quarter from $418000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $69000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 83.73% year-over-year to $69000.0; the TTM figure through Mar 2026 stood at $69000.0 (down 83.73% YoY), while the FY2025 annual figure was $418000.0, down 1.18% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $69000.0, down from $418000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $466000.0 in Q4 2023, with the low at $69000.0 in Q1 2026.
- The 5-year median for Other Non-Current Assets is $421000.0 (2024), against an average of $387000.0.
- The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets gained 26.98% in 2023, then sank 83.73% in 2026.
- TriSalus Life Sciences' Other Non-Current Assets stood at $367000.0 in 2022, then rose by 26.98% to $466000.0 in 2023, then decreased by 9.23% to $423000.0 in 2024, then decreased by 1.18% to $418000.0 in 2025, then sank by 83.49% to $69000.0 in 2026.
- Business Quant data shows TLSI's Other Non-Current Assets at $69000.0 in Q1 2026, $418000.0 in Q4 2025, and $419000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | TriSalus Life Sciences | 306.06 Mn | 259.77 Mn | 9.90 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 419,000.00 |
| Mar 31, 2025 | 424,000.00 |
| Dec 31, 2024 | 423,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 424,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Dec 31, 2022 | 367,000.00 |